Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Treatment of palmoplantar psoriasis with intramuscular alefacept.

Myers W, Christiansen L, Gottlieb AB.

J Am Acad Dermatol. 2005 Aug;53(2 Suppl 1):S127-9.

PMID:
16021161
2.

Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.

Bovenschen HJ, Gerritsen WJ, van Rens DW, Seyger MM, de Jong EM, van de Kerkhof PC.

Arch Dermatol Res. 2007 Feb;298(9):457-63. Epub 2006 Nov 30.

PMID:
17136563
3.

Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis.

Prossick TA, Belsito DV.

Cutis. 2006 Sep;78(3):178-80.

PMID:
17036660
4.

Alefacept.

Frampton J, Wagstaff A.

Am J Clin Dermatol. 2003;4(4):277-86; discussion 287. Review.

PMID:
12680805
5.

An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.

Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE; Alefacept Clinical Study Group.

Arch Dermatol. 2003 Jun;139(6):719-27.

PMID:
12810502
6.

Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis.

Perlmutter A, Cather J, Franks B, Jaracz E, Menter A.

J Am Acad Dermatol. 2008 Jan;58(1):116-24. Epub 2007 Nov 12.

PMID:
17997502
8.

Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.

Huang PH, Liao YH, Wei CC, Tseng YH, Ho JC, Tsai TF.

J Eur Acad Dermatol Venereol. 2008 Aug;22(8):923-30. doi: 10.1111/j.1468-3083.2007.02575.x. Epub 2008 Feb 27.

PMID:
18312328
9.
10.

Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.

Krueger GG.

Expert Opin Biol Ther. 2002 Apr;2(4):431-41. Review.

PMID:
11955280
11.
12.

Alefacept for the treatment of psoriasis and other dermatologic diseases.

Strober BE, Menon K.

Dermatol Ther. 2007 Jul-Aug;20(4):270-6. Review.

PMID:
17970892
13.

Alefacept treatment for chronic plaque psoriasis.

Dunn LK, Feldman SR.

Skin Therapy Lett. 2010 Apr;15(4):1-3. Review.

14.

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

Ellis CN, Krueger GG; Alefacept Clinical Study Group.

N Engl J Med. 2001 Jul 26;345(4):248-55.

15.

The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.

Langewouters AM, Bovenschen HJ, De jong EM, Van Erp PE, Van De Kerkhof PC.

J Dermatolog Treat. 2007;18(5):279-85.

PMID:
17852631
16.

An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.

Ortonne JP, Khemis A, Koo JY, Choi J.

J Eur Acad Dermatol Venereol. 2005 Sep;19(5):556-63.

PMID:
16164708
17.

Clinical update on alefacept: consideration for use in patients with psoriasis.

Gade JN.

J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S33-7. Review.

PMID:
15253688
18.

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study.

Gattu S, Busse K, Bhutani T, Chiang C, Nguyen T, Becker E, Koo JY.

J Dermatolog Treat. 2012 Apr;23(2):103-8. doi: 10.3109/09546634.2010.500323. Epub 2011 Jan 22.

PMID:
21254875
19.

Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.

Finlay AY, Salek MS, Haney J; Alefacept Clinical Study Group.

Dermatology. 2003;206(4):307-15.

PMID:
12771471
20.

Therapeutic hotline. Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis.

Lior S, Grigory K, Pnina S, Joseph S, Felix P.

Dermatol Ther. 2010 Sep-Oct;23(5):556-60. doi: 10.1111/j.1529-8019.2010.01361.x.

PMID:
20868412

Supplemental Content

Support Center